QUADRAMET DIN 02329999
Status: Cancelled Pre Market
Holder: SUPERNA LIFE SCIENCES INCORPORATED
Molecule: SAMARIUM (153SM) LEXIDRONAM
Health Canada record
| Active ingredient(s) | SAMARIUM (153SM) LEXIDRONAM 50 MCI |
|---|---|
| Dosage form | Liquid |
| Route | Intravascular; Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | |
| Original market date | |
| Current status date | 07-Sep-2022 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Request a quote for QUADRAMET